systemic acyclovir ( acv ) treatment has been shown to have significant effects on shortening the clinical course of first episode genital hsv infections , decreasing the quantity of hsv antibody in convalescent phase serum , without affecting the incidence of recurrences in 6 months of follow-up .
C0001367
acyclovir
C0019342
genital hsv infections